Bangor’s Clinical trial expertise recognised by UKCRC
The North Wales Organisation for Randomised Trials in Health (NWORTH Clinical Trials Unit) received further good news this week (last week they got their extension funding agreed by the Welsh Government) as they have been successfully re-accredited for a further 5 years following the 2017 Registration Review Process which was led by an International Review Committee of experts.
The Registration Process which has been running since 2007 is designed to signpost the available high-quality expertise to carry out clinical trials in the UK. Clinical Trials Units are specialist units that bring together the expertise needed to undertake a clinical trial, including statisticians, trial managers, information technology specialists and clinicians. As part of the registration process NWORTH had to demonstrate its capability to centrally coordinating multi-centre clinical trials and other well-designed studies, and to take overall responsibility for the design, conduct, data management, publicity and analysis of a trial in line with appropriate standards and regulations.
The feedback from the panel was NWORTH “…had presented a well-constructed and considered application which provided clear evidence of operational experience in the design and delivery of large scale multi-centre clinical trials”.
Professor Paul Brocklehurst, Director of NWORTH said “I am delighted with the news and this recognition highlights the strength of the unit which is a core element of Bangor’s Institute of Health & Medical Research in eth School of Healthcare Sciences. Getting UKCRC accreditation is recognition of the national standing of the Unit and follows a rigorous assessment process which some units in the UK did not pass.”
The full results are available here: http://www.ukcrc-ctu.org.uk/page/Results2017
Publication date: 23 August 2017